How have HQL shares performed in 2024?

Abrdn Life Sciences Investors' stock was trading at $13.46 at the start of the year. Since then, HQL shares have decreased by 4.9% and is now trading at $12.7950. View the best growth stocks for 2024 here .

Are investors shorting Abrdn Life Sciences Investors?

Abrdn Life Sciences Investors saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 21,300 shares, a decrease of 27.6% from the March 15th total of 29,400 shares. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is currently 0.2 days. View Abrdn Life Sciences Investors' Short Interest .

How often does Abrdn Life Sciences Investors pay dividends? What is the dividend yield for Abrdn Life Sciences Investors?

Abrdn Life Sciences Investors declared a quarterly dividend on Friday, February 9th. Investors of record on Thursday, February 22nd will be paid a dividend of $0.39 per share on Thursday, March 28th. This represents a $1.56 dividend on an annualized basis and a yield of 12.19%. The ex-dividend date is Wednesday, February 21st. This is a boost from the stock's previous quarterly dividend of $0.30. Read our dividend analysis for HQL .

Is Abrdn Life Sciences Investors a good dividend stock?

Abrdn Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.33 per share and currently has a dividend yield of 10.37%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL .

What ETF holds Abrdn Life Sciences Investors' stock?

Saba Closed-End Funds ETF holds 82,974 shares of HQL stock, representing 1.27% of its portfolio.

What other stocks do shareholders of Abrdn Life Sciences Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abrdn Life Sciences Investors investors own include NVIDIA (NVDA) , Energy Transfer (ET) , QUALCOMM (QCOM) , AT&T (T) , Enbridge (ENB) , International Business Machines (IBM) , Kinder Morgan (KMI) , Main Street Capital (MAIN) , Pfizer (PFE) and Weyerhaeuser (WY) .

Who are Abrdn Life Sciences Investors' major shareholders?

Abrdn Life Sciences Investors' stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.65%), 180 Wealth Advisors LLC (0.51%), Atlantic Union Bankshares Corp (0.12%) and Future Financial Wealth Managment LLC (0.01%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead , Kathleen Goetz and Todd Reit. View institutional ownership trends .

How do I buy shares of Abrdn Life Sciences Investors?

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:HQL

Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free HQL Stock Alerts

$12.80

+0.01 (+0.08%)

(As of 04/18/2024 ET)

Compare

Today's Range: $12.78
▼
$12.84
50-Day Range: $12.79
▼
$14.10
52-Week Range: $11.34
▼
$14.37

Volume: 147,902 shs
Average Volume: 112,256 shs
Market Capitalization: $335.36 million

P/E Ratio: N/A
Dividend Yield: 10.39%
Price Target: N/A

Get Abrdn Life Sciences Investors alerts:

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About Abrdn Life Sciences Investors Stock (NYSE:HQL)

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

HQL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HQL Stock News Headlines

March 21, 2024 | finance.yahoo.com

abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

March 8, 2024 | msn.com

SYRA: Takeaways from Life Science Investor Forum Presentation

April 18, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

March 1, 2024 | bizjournals.com

A 2024 life sciences outlook in Boston – and beyond

February 9, 2024 | markets.businessinsider.com

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in...

January 24, 2024 | benzinga.com

Peering Into Anavex Life Sciences's Recent Short Interest

November 23, 2023 | money.usnews.com

abrdn Life Sciences Investors

November 2, 2023 | investing.com

Abrdn Life Sciences Investors (HQL)

April 18, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

September 26, 2023 | finance.yahoo.com

Insider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...

September 21, 2023 | finance.yahoo.com

Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...

August 15, 2023 | seekingalpha.com

Tekla Life Sciences declares $0.32 dividend

June 20, 2023 | finance.yahoo.com

abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM

May 17, 2023 | msn.com

Tekla Life Sciences Investors (HQL) Declares $0.32 Dividend

May 15, 2023 | msn.com

Tekla Life Sciences dividend declines by 3% to $0.32

March 21, 2023 | seekingalpha.com

HQL Tekla Life Sciences Investors

November 18, 2022 | msn.com

Tekla Life Sciences: Dividend Insights

November 2, 2022 | fool.com

Tekla Life Sciences Investors (NYSE: HQL)

July 14, 2022 | seekingalpha.com

HQL: A Biotechnology Equity CEF With No Leverage

June 8, 2022 | news.yahoo.com

Tekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear Capsule

May 17, 2022 | seekingalpha.com

Tekla Life Sciences cuts dividend by 10% to $0.35

April 27, 2022 | seekingalpha.com

HQL: Buy For The Yield, If You Can Stomach The Depreciation

February 11, 2022 | seekingalpha.com

Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

January 18, 2022 | nasdaq.com

Tekla Life Sciences Investors Shares Approach 52-Week Low - Market Mover

August 15, 2021 | forbes.com

5 Dividend Funds Yielding Up To 27.2%

August 13, 2021 | nasdaq.com

Tekla Life Sciences Investors Shares Close in on 52-Week High - Market Mover

See More Headlines

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/28 Dividend: 2/21/2024
Dividend Payable: 3/28/2024
Today: 4/18/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Finance
Industry: Investment offices, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NYSE:HQL
CUSIP: N/A
CIK: 884121
Web: www.teklacap.com
Phone: (617) 772-8500
Fax: 617-772-8577
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 26,210,000
Free Float: 23,575,000
Market Cap: $335.23 million
Optionable: Not Optionable
Beta: 0.71

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Daniel R. Omstead M.S (Age 71)
Ph.D., Principal Executive Officer, President and Trustee
Mr. Peter Branner
Chief Investment Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HQL Stock Analysis - Frequently Asked Questions

How have HQL shares performed in 2024?: Abrdn Life Sciences Investors' stock was trading at $13.46 at the start of the year. Since then, HQL shares have decreased by 4.9% and is now trading at $12.7950.
View the best growth stocks for 2024 here.
Are investors shorting Abrdn Life Sciences Investors?: Abrdn Life Sciences Investors saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 21,300 shares, a decrease of 27.6% from the March 15th total of 29,400 shares. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is currently 0.2 days.
View Abrdn Life Sciences Investors' Short Interest.
How often does Abrdn Life Sciences Investors pay dividends? What is the dividend yield for Abrdn Life Sciences Investors?: Abrdn Life Sciences Investors declared a quarterly dividend on Friday, February 9th. Investors of record on Thursday, February 22nd will be paid a dividend of $0.39 per share on Thursday, March 28th. This represents a $1.56 dividend on an annualized basis and a yield of 12.19%. The ex-dividend date is Wednesday, February 21st. This is a boost from the stock's previous quarterly dividend of $0.30.
Read our dividend analysis for HQL.
Is Abrdn Life Sciences Investors a good dividend stock?: Abrdn Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.33 per share and currently has a dividend yield of 10.37%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

What ETF holds Abrdn Life Sciences Investors' stock?: Saba Closed-End Funds ETF holds 82,974 shares of HQL stock, representing 1.27% of its portfolio.
What other stocks do shareholders of Abrdn Life Sciences Investors own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Abrdn Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).
Who are Abrdn Life Sciences Investors' major shareholders?: Abrdn Life Sciences Investors' stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.65%), 180 Wealth Advisors LLC (0.51%), Atlantic Union Bankshares Corp (0.12%) and Future Financial Wealth Managment LLC (0.01%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead, Kathleen Goetz and Todd Reit.
View institutional ownership trends.
How do I buy shares of Abrdn Life Sciences Investors?: Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HQL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial